Showing results (121-130 of 190) with videos related to
Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|April 1, 1987
Elimination of enoxacin in renal diseaseR W Bury, G J Becker, P S Kincaid-Smith, et al.The New England Journal of Medicine|December 28, 1989
The effect of protein restriction on the progression of renal insufficiencyB U Ihle, G J Becker, J A Whitworth, et al.Cardiovascular and Interventional Radiology|May 1, 1994
Percutaneous angioplasty for atherosclerotic renal artery disease: effect on renal function in azotemic patientsP M Pattynama, G J Becker, J Brown, et al.Australian and New Zealand Journal of Medicine|February 1, 1980
Renal infection with Mycobacterium cheloneiG J Becker, R G Walker, L J Dziukas, et al.Nephron. Experimental Nephrology|June 9, 2005
Thrombin is a pro-fibrotic factor for rat renal fibroblasts in vitroT D Hewitson, M Martic, K J Kelynack, et al.Kidney International|September 1, 1993
Collagen studies in newborn rat kidneys with incomplete ureteric obstructionA Haralambous-Gasser, D Chan, R G Walker, et al.Journal of Vascular and Interventional Radiology : JVIR|August 1, 1992
Low-dose urokinase regimen for the treatment of lower extremity arterial and graft occlusions: experience in 132 casesS D LeBlang, G J Becker, J F Benenati, et al.Kidney International|April 14, 1999
Tissue factor pathway inhibitor expression in human crescentic glomerulonephritisM A Cunningham, T Ono, T D Hewitson, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2000
Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failureL P McMahon, K Mason, S L Skinner, et al.The Quarterly Journal of Medicine|January 1, 1985
Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndromeR G Walker, C Scheinkestel, G J Becker, et al.Pageof 19